The DOI matches its Crossref record; 14 of the 16 references it cites were found in a registry or an index.
Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease
Abstract
The safety and tolerability of high dosages of coenzyme Q10 were studied in 17 patients with Parkinson's disease (PD) in an open label study. The subjects received an escalating dosage of coenzyme Q10--1200, 1800, 2400, and 3000 mg/day with a stable dosage of vitamin E (alpha-tocopherol) 1200 IU/day. The plasma level of coenzyme Q10 was measured at each dosage. Thirteen of the subjects achieved the maximal dosage, and adverse events were typically considered to be unrelated to coenzyme Q10. The plasma level reached a plateau at the 2400 mg/day dosage and did not increase further at the 3000 mg/day dosage. Our data suggest that in future studies of coenzyme Q10 in PD, a dosage of 2400 mg/day (with vitamin E/alpha-tocopherol 1200 IU/day) is an appropriate highest dosage to be studied.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, plasma CoQ10 levels reached a plateau at the 2400 mg/day dosage and did not increase further at the 3000 mg/day dosage in PD, HD or ALS patients161, 162.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [161]
Citations
Cites
Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline
Shults, C. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1541 · Cited by 984
Self-citationStocker, R., Bowry, V. W., & Frei, B. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1646 · Cited by 797
Mohr, D., Bowry, V. W., & Stocker, R. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90237-p · Cited by 313
Biomedical and clinical aspects of coenzyme Q
Littarru, G. P. (1993) · Journal of Molecular Medicine · doi:10.1007/bf00184478 · Cited by 310
Lass, A., & Sohal, R. S. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0606 · Cited by 162
Lass, A., & Sohal, R. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.1.87 · Cited by 128
Bioavailability of four oral Coenzyme Q10 formulations in healthy volunteers
Weis, M., Mortensen, S. A., Rassing, M. R., Sonnergaard, J. M., Poulsen, G., & Rasmussen, S. N. (1994) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(94)90038-8 · Cited by 102
Kontush, A., Hübner, C., Finckh, B., Kohlschütter, A., & Beisiegel†, U. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00115-s · Cited by 75
Pharmacokinetic study of deuterium-labelled coenzyme Q10 in man.
Tomono, Y., Hasegawa, J., Seki, T., Motegi, K., & Morishita, N. (1986) · PubMed · Cited by 73
Interactions between ubiquinones and vitamins in membranes and cells
Constantinescu, A., Maguire, J. J., & Packer, L. (1994) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(94)90013-2 · Cited by 73
Flagged first, then by citations
2 of the 16 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 222
Coenzyme Q10 in the Treatment of Mitochondrial Disease
Neergheen, V., Chalasani, A., Wainwright, L., Yubero, D., Montero, R., Artuch, R., & Hargreaves, I. P. (2017) · Journal of Inborn Errors of Metabolism and Screening · doi:10.1177/2326409817707771 · Cited by 44
Liu, Z.-X., & Artmann, C. (2009) · PubMed · Cited by 41
Recovery of solanesol from tobacco as a value-added byproduct for alternative applications
Machado, P. A., Fu, H., Kratochvil, R. J., Yuan, Y., Hahm, T., Sabliov, C. M., Wei, C., & Lo, Y. M. (2009) · Bioresource Technology · doi:10.1016/j.biortech.2009.09.009 · Cited by 40
Does High-Dose Coenzyme Q 10 Improve Oxidative Damage and Clinical Outcomes in Parkinson's Disease?
Seet, R. C. S., Lim, E. C. H., Tan, J. J. H., Quek, A. M. L., Chow, A. W. L., Chong, W.-L., Ng, M. P.-E., Ong, C. N., & Halliwell, B. B. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5801 · Cited by 39
Müller, T. H. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.50 · Cited by 40
Medical Management of Parkinsons Disease: Focus on Neuroprotection
Rı́os, C., Boll, M., & Alcaraz-Zubeldia, M. (2011) · Current Neuropharmacology · doi:10.2174/157015911795596577 · Cited by 39
Huntington's disease: progress and potential in the field
Stack, E. C., & Ferrante, R. J. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.12.1933 · Cited by 39
Genotype-driven therapeutic developments in Parkinson’s disease
Prasuhn, J., & Brüggemann, N. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00281-8 · Cited by 42
Parkinson’s disease: an update on pathogenesis and treatment
Foltynie, T., & Kahan, J. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6915-1 · Cited by 39
Coenzyme Q10 for Parkinson's disease
Liu, J., Wang, L., Zhan, S.-Y., & Xia, Y. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008150.pub2 · Cited by 36
RetractedCoenzyme Q10 and Dementia: A Systematic Review
Jiménez‐Jiménez, F. J., Alonso‐Navarro, H., García‐Martín, E., & Agúndez, J. A. G. (2023) · Antioxidants · doi:10.3390/antiox12020533 · Cited by 35
Coenzyme Q10 oral bioavailability: effect of formulation type
Barakat, A., Shegokar, R., Dittgen, M., & Müller, R. H. (2013) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-013-0101-4 · Cited by 35
Chapter 28 Identification of Novel Pharmacological Targets to Minimize Excitotoxic Retinal Damage
Russo, R., Rotiroti, D., Tassorelli, C., Nucci, C., Bagetta, G., Bucci, M. G., Corasaniti, M. T., & Morrone, L. A. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)85028-9 · Cited by 34
Hickey, M. A., Zhu, C., Medvedeva, V. P., Franich, N. R., Levine, M. S., & Chesselet, M. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.10.007 · Cited by 35
Deelchand, D. K., Joers, J. M., Ravishankar, A., Lyu, T., Emir, U. E., Hutter, D., Gomez, C. M., Bushara, K. O., Lenglet, C., Eberly, L. E., et al. (2019) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12804 · Cited by 36
Donovan, L., & Severin, N. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1498 · Cited by 36
Coenzyme Q10 for Parkinson's disease
Liu, J., Wang, L., Zhan, S.-Y., & Xia, Y. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008150.pub3 · Cited by 32
RetractedTsuneki, H., Tokai, E., Suzuki, T., Seki, T., Okubo, K., Wada, T., Okamoto, T., Koya, S., Kimura, I., & Sasaoka, T. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.12.027 · Cited by 32
Fogagnolo, P., Sacchi, M. M., Ceresara, G., Paderni, R., Lapadula, P., Orzalesi, N., & Rossetti, L. M. (2012) · Ophthalmologica · doi:10.1159/000342196 · Cited by 30
Li, G., Jack, C. R., Yang, X., & Yang, E. S. (2008) · BioFactors · doi:10.1002/biof.5520320120 · Cited by 30
Emerging chemotherapeutic strategies for Huntington’s disease
Ryu, H., & Ferrante, R. J. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.2.345 · Cited by 30
Protein Nanoparticles for Enhanced Oral Delivery of Coenzyme-Q10: in Vitro and in Silico Studies
Banun, V. J., Rewatkar, P. V., Chaudhary, Z., Qu, Z., Janjua, T. I., Patil, A., Wu, Y., Ta, H. T., Bansal, N., Miles, J. A., et al. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01354 · Cited by 27
Combined Supplementation of Coenzyme Q10 and Other Nutrients in Specific Medical Conditions
Tippairote, T., Bjørklund, G., Gasmi, A., Semenova, Y. M., Peana, M., Chirumbolo, S., & Hangan, T. (2022) · Nutrients · doi:10.3390/nu14204383 · Cited by 28
Li, G., Zou, L., Jack, C. R., Yang, Y., & Yang, E. S. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.005 · Cited by 25
Coenzyme Q10 Absorption and Tolerance in Children With Down Syndrome: A Dose-Ranging Trial
Miles, M. V., Patterson, B. J., Schapiro, M. B., Hickey, F. J., Chalfonte-Evans, M., Horn, P. S., & Hotze, S. L. (2006) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2005.11.004 · Cited by 25
Coenzyme Q10 and Parkinsonian Syndromes: A Systematic Review
Jiménez‐Jiménez, F. J., Alonso‐Navarro, H., García‐Martín, E., & Agúndez, J. A. G. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12060975 · Cited by 24
New Therapeutic Approaches to Parkinson’s Disease Including Neural Transplants
Kuan, W., & Barker, R. (2005) · Neurorehabilitation and neural repair · doi:10.1177/1545968305277219 · Cited by 23
Camins, A., Sureda, F. X., Junyent, F., Verdaguer, E., Folch, J., Beas‐Zárate, C., & Pallàs, M. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543781003781898 · Cited by 24
Taylor, B. A. (2017) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-017-0251-2 · Cited by 22
Effects of estrogens and androgens on mitochondria under normal and pathological conditions
Mohajeri, M., Martín-Jiménez, C., Barreto, G. E., & Sahebkar, A. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.03.001 · Cited by 23
Acute, subacute toxicity and genotoxic effect of Bio-Quinone® Q10 in mice and rats
Fu, X., Ji, R., & Dam, J. (2008) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2008.09.003 · Cited by 22
Mitochondria: Prospective Targets for Neuroprotection in Parkinson’s Disease
Yadav, A., Agarwal, S., Tiwari, S. K., & Chaturvedi, R. K. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140305224545 · Cited by 22
Alam, M., Yadav, R. K., Minj, E., Tiwari, A., & Mehan, S. (2020) · Current Molecular Pharmacology · doi:10.2174/1566524020666200427214356 · Cited by 21
Experimental Models of HD and Reflection on Therapeutic Strategies
Kim, J., Bordiuk, O. L., & Ferrante, R. J. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-381328-2.00016-x · Cited by 20
Prangthip, P., Kettawan, A., Posuwan, J., Okuno, M., & Okamoto, T. (2016) · Journal of Dietary Supplements · doi:10.3109/19390211.2016.1164788 · Cited by 19
Emerging drugs for Parkinson’s disease
Morgan, J. C., & Sethi, K. D. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.3.403 · Cited by 19
Marashi, S. M., Majidi, M., Sadeghian, M., Jafarzadeh, M., Mohammadi, S., & Nasri-Nasrabadi, Z. (2015) · Tzu Chi Medical Journal · doi:10.1016/j.tcmj.2014.12.002 · Cited by 17
Saeed, A., Qusti, S. Y., Almarwani, R. H., Jambi, E. J., Alshammari, E. M., Gusty, N. F., & Balgoon, M. J. (2021) · RSC Advances · doi:10.1039/d1ra03786b · Cited by 16
Parkinson Symptom Severity and Use of Nutraceuticals
Mischley, L. K., Farahnik, J., Mantay, L., Punzi, J., Szampruch, K., Ferguson, T., & Fox, D. J. (2023) · Nutrients · doi:10.3390/nu15040802 · Cited by 15
New prospects and strategies for drug target discovery in neurodegenerative disorders
Hilbush, B. S., Morrison, J. H., Young, W. G., Sutcliffe, J. G., & Bloom, F. E. (2005) · NeuroRx · doi:10.1602/neurorx.2.4.627 · Cited by 14
Dowaidar, M. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/pdzqb · Cited by 18
Wu, Y.-L., Chang, J.-C., Sun, H.-L., Cheng, W.-L., Yen, Y.-P., Lin, Y., Chao, Y.-C., Liu, K.-H., Huang, C.-S., Liu, K.-L., et al. (2022) · Nutrients · doi:10.3390/nu14173593 · Cited by 12
Neuroprotection in Parkinson's Disease: A Systematic Review of the Preclinical Data
Douna, H., Bavelaar, B. M., Pellikaan, H., Olivier, B., & Pieters, T. (2012) · The Open Pharmacology Journal · doi:10.2174/1874143601206010012 · Cited by 13
Koenzym Q10 beim Morbus Parkinson
Storch, A. (2007) · Der Nervenarzt · doi:10.1007/s00115-007-2285-1 · Cited by 13
MMP-Sensitive Macrophage-Targeted Coenzyme Q10 Nanomedicine for Rheumatoid Arthritis Treatment
Akram, A., Ara, N., Bhattarai, P., Irfan, M., & Zhu, L. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00742 · Cited by 14
Hormozi, M., Mirzaei, R., Nakhaee, A., Payandeh, A., Izadi, S., & Haghighi, J. D. (2018) · Toxicology and Industrial Health · doi:10.1177/0748233718809256 · Cited by 12
Banerjee, P., Saha, I., Sarkar, D., & Maiti, A. K. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00501-x · Cited by 13
The Impact of Coenzyme Q10 on Neurodegeneration: a Comprehensive Review
Kadian, M., Sharma, G., Pandita, S., Sharma, K., Shrivasatava, K., Saini, N., & Kumar, A. (2022) · Current Pharmacology Reports · doi:10.1007/s40495-021-00273-6 · Cited by 11
Nukui, K., Yamagishi, T., Miyawaki, H., Kettawan, A., Okamoto, T., Belardinelli, R., Tiano, L., Littarru, G. P., & Sato, K. (2008) · BioFactors · doi:10.1002/biof.5520320125 · Cited by 10
Enhancement of antibody production by the addition of Coenzyme-Q10
Konno, Y., Aoki, M., Takagishi, M., Sakai, N., Koike, M., Wakamatsu, K., & Hosoi, S. (2010) · Cytotechnology · doi:10.1007/s10616-010-9330-9 · Cited by 10
Relative Bioavailability of Coenzyme Q10 in Emulsion and Liposome Formulations
Choi, C.-H., Kim, S.-H., Shanmugam, S., Baskaran, R., Park, J., Yong, C.-S., Choi, H.-G., Yoo, B. K., & Han, K. (2010) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2010.18.1.099 · Cited by 10
The Evolution of Pharmacological Treatment for Parkinsons Disease
Almeida, Q. J., & Hyson, H. C. (2008) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488908783421500 · Cited by 10
Oral Repeated-Dose Toxicity Studies of Coenzyme Q10 in Beagle Dogs
Yerramilli-Rao, P., Beal, M. F., Watanabe, D., Kieburtz, K. D., de Blieck, E. A., Kitano, M., Hosoe, K., Funahashi, I., & Cudkowicz, M. (2012) · International Journal of Toxicology · doi:10.1177/1091581811425256 · Cited by 9
Nutraceuticals and Other Natural Products in Parkinson’s Disease Therapy
Mythri, R. B., Joshi, A. K. R., & Bharath, M. M. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411462-3.00044-8 · Cited by 9
The effect of coenzyme Q10 on the pharmacokinetic parameters of theophylline
Baskaran, R., Shanmugam, S., Nagayya-Sriraman, S., Kim, J. H., Jeong, T. C., Yong, C. S., Choi, H.-G., & Yoo, B. K. (2008) · Archives of Pharmacal Research · doi:10.1007/s12272-001-1250-1 · Cited by 9
Can we prevent parkinson's disease?
Christine, R. V. (2009) · Frontiers in bioscience · doi:10.2741/3331 · Cited by 9
Conditionally Essential Nutrients: The State of the Science
(2018) · doi:10.17303/jfn.2014.1.e204 · Cited by 8
Transplant and risk of Parkinson disease
Fan, J. H., Nielsen, S. S., Faust, I. M., & Racette, B. A. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.02.013 · Cited by 8
Kawasaki, T. (2012) · The Open Nutraceuticals Journal · doi:10.2174/1876396001205010187 · Cited by 8
Halder, S., Nasrin, F., Shill, M. C., Shuma, M. L., Sultan, M. Z., & Reza, M. S. (2025) · Scientifica · doi:10.1155/sci5/9034181 · Cited by 7
Coenzyme Q10 and Cognition: A Review
Nankivell, M. C., Rosenfeldt, F., Pipingas, A., Pase, M. P., Reddan, J. M., & Stough, C. K. K. (2025) · Nutrients · doi:10.3390/nu17172896 · Cited by 9
High-Sensitivity Simultaneous Analysis of Ubiquinol-10 and Ubiquinone-10 in Human Plasma
Hirayama, A., Kubo, H., Mita, M., Shirota, O., & Yamamoto, Y. (2008) · Journal of Chromatographic Science · doi:10.1093/chromsci/46.8.717 · Cited by 7
Coenzyme Q 10 and the exclusive club of diseases that show a limited response to treatment
Turton, N., Bowers, N. L., Khajeh, S., Hargreaves, I. P., & Heaton, R. A. (2021) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2021.1932459 · Cited by 7
Bioavailability of Reduced Coenzyme Q10 (Ubiquinol-10) in Burn Patients
Kuriyama, N., Nakamura, T., Nakazawa, H., Wen, T., Berra, L. M., Bittner, E. A., Goverman, J. M., & Kaneki, M. (2022) · Metabolites · doi:10.3390/metabo12070613 · Cited by 7
Coenzyme Q10 therapy in current clinical practice
Soni, A., Verma, M., Kaushal, V., & Ghalaut, V. S. (2015) · International Journal of Research in Medical Sciences · doi:10.5455/2320-6012.ijrms20150401 · Cited by 7
Zhang, F., Liu, Y., Zhu, Y., Yu, Q.-Y., Msigwa, S. S., Zeng, Z.-H., Zhang, X., Wu, H.-M., & Zhu, J. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.01.028 · Cited by 7
Antioxidant modulation in restoring mitochondrial function in neurodegeneration
Arrozi, A. P., Ngah, W. Z. W., Yusof, Y. A. M., Damanhuri, H. A., & Makpol, S. (2016) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1178261 · Cited by 7
Saadh, M. J., Saeed, T. N., Al-Hussainy, A. F., Kyada, A., Ballal, S., Kundlas, M., Sabarivani, A., Rizaev, J. A., Taher, S. G., Alwan, M., et al. (2025) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2025.2541698 · Cited by 6
Functional foods and cognition
Scholey, A. B., Camfield, D., Owen, L., Pipingas, A., & Stough, C. K. K. (2011) · Elsevier eBooks · doi:10.1533/9780857092557.2.277 · Cited by 5
Targeting Antioxidants to Mitochondria by Conjugation to Lipophilic
Murphy, M. P., & Smith, R. A. J. (2007) · Cited by 5
Tian, Y., Machado, P. A., Fu, H., Hahm, T., Wei, C., & Lo, Y. M. (2020) · Journal of Food and Drug Analysis · doi:10.38212/2224-6614.2147 · Cited by 5
Greenlee, H., Crew, K. D., Maurer, M., Kalinsky, K. M., Cremers, S., Naini, A., Tsai, W. Y., Shi, Z., Brogan, F., & Hershman, D. L. (2025) · Integrative Cancer Therapies · doi:10.1177/15347354251388014 · Cited by 4
Method for detecting CoQ10 incorporation in the mitochondrial respiratory chain supercomplex
Sugawara, K., Sato, S., Tanaka, Y., Nakamura, A., Fujisawa, A., Yamamoto, Y., & Kashiba, M. (2023) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.22-137 · Cited by 4
Zaleski, A. L. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-33304-1_15 · Cited by 4
Al‐Taie, A., Arueyingho, O., & Hafeez, A. (2021) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-021-00819-1 · Cited by 4
Dietary Supplements: Current Knowledge and Future Frontiers
Costello, R. B., Leser, M., & Coates, P. M. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-385-5_28 · Cited by 4
Vachirarojpisan, T., Srivichit, B., Vaseenon, S., Powcharoen, W., & Imerb, N. (2024) · Nutrition Research · doi:10.1016/j.nutres.2024.07.011 · Cited by 5
van Diemen, M. P. J., Hart, E. P., Hameeteman, P. W., Coppen, E. M., Winder, J. Y., den Heijer, J. M., Moerland, M., Kan, H. E., van der Grond, J., WEBB, A. G., et al. (2020) · Journal of Huntington s Disease · doi:10.3233/jhd-200413 · Cited by 3
Sarkar, M., Bag, P., Kumar, B., & Chawla, P. A. (2021) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.875 · Cited by 3
Coenzyme Q10 for Enhancing Physical Activity and Extending the Human Life Cycle
Bjørklund, G., Semenova, Y. M., Gasmi, A., Indika, N.-L. R., Hrynovets, I., Lysiuk, R., Lenchyk, L. V., Uryr, T., Yeromina, H. О., & Peana, M. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230228103913 · Cited by 3
Can Coenzyme Q10 Lead to Improvement of Essential Hypertension?: A Long-Term Case Study
Kimura, I., Kimura, M., Tsuneki, H., Sasaoka, T., & Koya, S. (2008) · Eisei kagaku · doi:10.1248/jhs.54.571 · Cited by 4
Freye, E. C. K., & Strobel, H. P. (2015) · International Journal of Pharmacology Phytochemistry and Ethnomedicine · doi:10.18052/www.scipress.com/ijppe.1.65 · Cited by 2
Hosseini-Ghalibaf, S.-N., Ranjbar, A., Yasrebifar, F., Mirzaei, E., Mirjalili, M., Mohammadi, Y., & Mehrpooya, M. (2020) · The Natural Products Journal · doi:10.2174/2210315509666190624102012 · Cited by 2
Alleviating Congestive Heart Failure with Coenzyme Q10
Langsjoen, P. H. (2008) · Cited by 2
The Role of Coenzyme Q10 Supplementation with Statin Drug Use and Chronic Diseases
Peres, H. A., Foss, M. C. F., & Pereira, L. R. L. (2017) · Journal of Ancient Diseases & Preventive Remedies · doi:10.4172/2329-8731.1000157 · Cited by 2
Drug-induced mitochondrial impairment: Mechanisms and testing systems
Heidari, R., Ommati, M. M., & Niknahad, H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-88462-4.00009-2 · Cited by 2
Coenzym Q10 – der mitochondriale Blockbuster
Gröber, U. (2018) · Zeitschrift für Orthomolekulare Medizin · doi:10.1055/a-0584-8688 · Cited by 2
Targeted Delivery of Nutraceuticals Using Nanoparticles
(2016) · Nutraceuticals · doi:10.1201/9781315370859-6 · Cited by 2
An Overview of Target Specific Neuro-Protective and Neuro-Restorative Strategies
Al, A., Al, K., Al-, A., Arshaduddin, M., & Tariq, M. (2012) · InTech eBooks · doi:10.5772/34731 · Cited by 1
Freye, E. C. K., & Strobel, H. P. (2016) · Natural Products Chemistry & Research · doi:10.4172/2329-6836.1000233 · Cited by 1
Freye, E., & Strobel, H. P. (2016) · Natural Products Chemistry & Research · doi:10.4172/2339-6836.1000233 · Cited by 1
Dietary Supplements in Older Adults
Dwyer, J. T., Costello, R. B., Merkel, J. M., & Coates, P. M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1929-1_23 · Cited by 1
Facecchia, K. (2012) · Scholarship at UWindsor (University of Windsor) · Cited by 1
Enhancement of antibody production by the addition
KonnoMotoi, Y. (2011) · Cited by 1
Suplementy diety w Polsce, ze szczególnym uwzględnieniem produktów dla osób starszych
Stos, K., Krygier, B., Głowala, A., & Jarosz, M. (2014) · Żywienie Człowieka i Metabolizm
Metabolic Regulation of Endothelial Dysfunction and Cardiovascular Risk
Young, J. M. (2012) · Otago University Research Archive (University of Otago)
Dietary Factors in Geriatric Neurology
Gu, Y., & Scarmeas, N. (2014) · Wiley eBooks · doi:10.1002/9781118730676.ch27
Natural Health Products in Parkinson Disease
Sadowski, C. A., & Heschuk, S. (2010) · Health care and disease management · doi:10.1002/9783527629480.ch6
Pavlin, R. (2008) · Slovenian Medical Journal
Metadata
- Authors
- Shults, C. W., Flint Beal, M., Song, D., & Fontaine, D.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Shults, Clifford W.
- ORCID
- Song, David
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2004-08
- Volume
- 188
- Issue
- 2
- Pages
- 491-494
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W1990908870
- Cited by
- 223
- References
- 16
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 1 · 2023: 8 · 2022: 8 · 2021: 10 · 2020: 8 · 2019: 6 · 2018: 6 · 2017: 7 · 2016: 9 · 2015: 7 · 2014: 13 · 2013: 13 · 2012: 13
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- coenzyme Q10, Parkinson's disease, high-dose supplementation, vitamin E, alpha-tocopherol, safety and tolerability, dose escalation, adverse events
- MeSH terms
- Calcium, Coenzymes, Cognition, Dose-Response Relationship, Drug, Drug Therapy, Combination, Dyspepsia, Female, Humans, Male, Middle Aged, Motor Activity, Parkinson Disease, Pilot Projects, Safety, Time Factors, Ubiquinone, Vitamin E
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review